Table 3.
Demographic, Clinical Features, and Laboratory Results of Participant Distinguished by the 14 Days
| Characteristics | Viral Shedding (Days≤14) | Viral Shedding (Days>14) | P value |
|---|---|---|---|
| Patients (n=631) | 434(69.1%) | 197(30.9%) | |
| Gender | |||
| Female | 230(52.9%) | 80(40.6%) | <0.01 |
| Male | 204(46.1%) | 117(59.4%) | |
| Age (years) | |||
| 18–45 | 83(19.1%) | 45(22.8%) | 0.427 |
| 46–69 | 187(43.1%) | 78(39.6%) | |
| >69 | 164(37.8%) | 74(37.6%) | |
| Smoking | |||
| Yes | 10(2.3%) | 3(1.5%) | 0.537 |
| No | 424(97.7%) | 194(98.5%) | |
| Comorbidities | |||
| Yes | 255(58.8%) | 108(54.8%) | 0.367 |
| No | 179(41.2%) | 89(45.2%) | |
| None of Comorbidities | |||
| 1 | 172(39.6%) | 75(38.1%) | 0.833 |
| 2 | 75(17.3%) | 28(14.2%) | |
| ≥3 | 8(1.8%) | 5(2.5%) | |
| Vaccination (time) | |||
| 0 | 208(47.9%) | 116(58.9%) | <0.05 |
| 1 | 24(5.5%) | 12(6.1%) | |
| 2 | 90(20.7%) | 35(17.8%) | |
| 3 | 112(25.8%) | 34(17.3%) | |
| Fever | |||
| Yes | 139(32.0%) | 65(33.0%) | 0.860 |
| No | 295(68.0%) | 132(67.0%) | |
| Cough | |||
| Yes | 190(43.8%) | 89(45.2%) | 0.758 |
| No | 244(56.2%) | 108(54.8%) | |
| Pharyngalgia | |||
| Yes | 91(20.9%) | 31(15.7%) | 0.144 |
| No | 343(79.1%) | 166(84.3%) | |
| Dyspnea | |||
| Yes | 11(2.5%) | 9(4.6%) | 0.166 |
| No | 423(97.5%) | 188(95.4%) | |
| Constipation | |||
| Yes | 53(12.2%) | 39(19.8%) | <0.05 |
| No | 381(87.8%) | 158(80.2%) | |
| Insomnia | |||
| Yes | 49(11.3%) | 14(7.1%) | 0.116 |
| No | 385(88.7%) | 183(92.9%) | |
| IgG | |||
| Negative | 292(67.3%) | 100(50.8%) | <0.01 |
| Weakly positive | 3(0.7%) | 5(2.5%) | |
| Positive | 139(32.0%) | 92(46.7) | |
| IgM | |||
| Negative | 419(96.5%) | 188(95.4%) | 0.514 |
| Weakly positive | 6(1.4%) | 2(1.0%) | |
| Positive | 9(2.1%) | 7(3.6%) | |
| NCt (Median, Quartile) | 26.3(21.1,34.8) | 36.2(22.7,45.5) | <0.01 |
| ORF1abCt (Median, Quartile) | 28.4(23.4,36.9) | 37.7(25.1,50.0) | <0.01 |
| From the onset of positive to the admission to hospital (Median, Quartile) | 3(2,7) | 14(5,19) | <0.01 |
| From hospitalization to viral shedding (Median, Quartile) | 5(2,8) | 4(1,12) | 0.984 |
| Lymphocyte (95% confidence interval)(percent) | 29.9(28.9,30.9) | 27.0(25.4,28.6) | <0.05 |
| Hb (Median, Quartile) | 129(119,141) | 127(115,142) | 0.111 |
| hsCRP (Median, Quartile) | 2.49(0.25,6.47) | 1.64(0.25,6.35) | 0.117 |
| D dimer | 0.35(0.21,0.69) | 0.38(0.21,0.82) | 0.435 |
| CD4+T Number | 565(354,821) | 578(409,804) | 0.582 |
| CD4+T Number (95% confidence interval)(percent) | 41.1(40.3,41.9) | 40.1(38.6,41.5) | 0.186 |
| TNF-α (Median, Quartile) | 0.34(0.06,0.96) | 0.41(0.13,1.11) | 0.296 |
| IL1-β (Median, Quartile) | 3.04(1.14,6.96) | 3.24(1.29,7.49) | 0.608 |
| IL-2 (Median, Quartile) | 0.66(0.35,1.42) | 0.7(0.41,1.27) | 0.803 |
| IL-6 (Median, Quartile) | 1.77(0.91,3.54) | 1.84(0.85,3.81) | 0.872 |
| IL-8 (Median, Quartile) | 0.01(0.00,12.6) | 0.00(0.00,6.29) | 0.212 |
| IL12p70 (Median, Quartile) | 0.95(0.76,1.21) | 0.95(0.76,1.20) | 0.786 |
| IL17 (Median, Quartile) | 2.55(1.58,3.99) | 2.55(1.73,3.83) | 0.942 |
| IFN-γ (Median, Quartile) | 1.93(1.09,3.39) | 1.59(0.92,3.06) | 0.103 |
Abbreviations: NCt, N gene cycle threshold; ORF1abCt, ORF1ab gene cycle threshold; Hb, Hemoglobin; hsCRP, hypersensitive C-reactive protein; TNF-α, tumor necrosis factor-α; IL, Interleukin; IFN-γ, Interleukin.